Bicara Therapeutics Inc. - Common Stock, par value $0.0001 per share (BCAX)

CUSIP: 055477103

Q3 2025 13F Holders as of 30 Sep 2025

Security type / class
Equity / Common Stock, par value $0.0001 per share
Total 13F shares
49,994,786
Total 13F value
$789,088,187
Holder snapshot 6 signals
Share change
-1,056,866
SEC-reported price per share
$15.79
Number of holders
112
Value change
+$2,780,392
Number of buys
63
Number of sells
43
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
65,361,446

Security key

055477103

Report period

Q3 2025

Institutions

112

Top holders

10

BCAX full security history Ownership snapshot Full 13F holder table Newer quarter: Q4 2025 Previous quarter: Q2 2025 Bicara Therapeutics Inc. SEC filings Bicara Therapeutics Inc. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Ownership snapshot

Top reported holders of BCAX - Bicara Therapeutics Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Invus Global Management, LLC
Disclosed value leader
RA CAPITAL MANAGEMENT, L.P.
Comparable rows
15/15
Latest evidence
30 Jun 2025
13D/G 13F 3/4/5 Lead comparable stake: 9.6% 13D/G row: Invus Global Management, LLC Showing 1-6 of 15 holder rows.

Quick read

Invus Global Management, LLC leads the comparable SEC ownership view at 9.6%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Invus Global Management, LLC's linked filing trail.
Comparable ownership Top 5
Invus Global Management, LLC 9.6%
RA CAPITAL MANAGEMENT, L.P. 11%
Siren, L.L.C. 8%
Vestal Point Capital, LP 7.6%
Red Tree Management, LLC 4.9%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Invus Global Management, LLC
13D/G
Raymond Debbane
13D/G
9.6%
$50,656,769
5,216,969 shares
 $0 30 Jun 2025
RA CAPITAL MANAGEMENT, L.P.
13F
Company
13F
11%
$64,621,175
6,955,993 shares
 — 30 Jun 2025
Siren, L.L.C.
13F
Individual
13F
8%
$48,465,642
5,216,969 shares
 — 30 Jun 2025
Vestal Point Capital, LP
13F
Company
13F
7.6%
$46,450,000
5,000,000 shares
 — 30 Jun 2025
Red Tree Management, LLC
13F
Company
13F
4.9%
$29,454,029
3,170,509 shares
 — 30 Jun 2025
TPG GP A, LLC
13F 3/4/5
Company · Former 10% Owner
13F 3/4/5
4.6%
$27,966,848
3,010,425 shares
 — 30 Jun 2025
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q3 2025

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
112
Shares
49,994,786
Rows available
112
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q3 2025 vs Q2 2025 Across Filers

Q2 2025 holders
105
Q3 2025 holders
112
Holder diff
7
Investor Q2 2025 Shares Q3 2025 Shares Share Diff Share Chg % Q2 2025 value Q3 2025 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .